Status:
RECRUITING
Exercise Therapy on Rheological Functions of Erythrocyte in Hemodialysis
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Hemodialysis Complication
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
To improve aerobic capacity, muscular function, and health-related quality of life in patients with end-stage renal disease (ESRD), regular exercise is recommended. Supervised intradialytic exercise a...
Detailed Description
Renal dysfunction often stems from cardiovascular-related comorbidities or metabolic disorders, leading to the accumulation of excessive inflammatory products or damaging the bioenergetic health of re...
Eligibility Criteria
Inclusion
- Receiving hemodialysis and medication at least for 6 weeks
- Kt/V score \> 1.2
Exclusion
- Under 20 years-old
- Hyperkalemia occurs within 3 month
- Having orthopedic or muscular diseases
- Other concerned medical, psychological or physiological diseases
- Pregnancy
- Other exercise contraindications
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT06575634
Start Date
August 1 2022
End Date
July 31 2025
Last Update
August 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung University
Taoyuan District, Taiwan, 333